About
Us2Ai develops FDA-cleared AI software that automates the analysis and reporting of echocardiograms to provide comprehensive cardiac assessments including disease detection such as cardiac amyloidosis.
Explore Us2Ai's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.